Altogether the hypermethylated CEACAM5 group showed these clinical features resemble the CMS1 classification of CRC with a BRAF mutation, TGFB2 mutation, MSI‐H, and proximally located colon tumor.4 This evidence concerns the gene TGFB2 and colonic neoplasm.